HILARY UGRAS: Open Payments
NPI 1083099840 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,158 in 29 payments from 6 companies in 2025. Trend: 2023 $154 · 2024 $4,927 · 2025 $13,158
Consulting: $5,685Speaker / faculty: $5,548Travel & lodging: $1,173Food & beverage: $752
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $5,884 |
| Regeneron Healthcare Solutions, Inc. | 16 | $4,367 |
| Regeneron Pharmaceuticals, Inc. | 3 | $1,494 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,084 |
| Phathom Pharmaceuticals, Inc. | 3 | $222 |
| Ipsen Biopharmaceuticals, Inc | 1 | $107 |
Products named: DUPIXENT, EOHILIA, VOQUEZNA, Bylvay.
Industry payments across MA — which companies pay providers there.
